1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Tom Appleton: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis Adalimumab, Prednisone - Inflammatory Arthritis, Immune-related Adverse Event | Phase 2 | Recruiting | Tom Appleton | 30 | 2024-04-15 | 2026-03-03 |
Arthritis (1)
Adalimumab (1) · Adrenal Cortex Hormones (1) · Glucocorticoids (1) · Prednisone (1)
Canada (1)